NCT02139696View on ClinicalTrials.gov

Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

October 31, 2016

Conditions
Multiple Sclerosis
Interventions
RADIATION

PET and MRI

Patients will be imaged using PET and MRI at baseline, and twice during treatment

Trial Locations (1)

20520

Turku University Hospital, Turku

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT02139696 - Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation | Biotech Hunter | Biotech Hunter